|
Volumn 42, Issue 5, 2015, Pages 581-583
|
Hange-shashin- to for preventing diarrhea during afatinib therapy
a a a a a a a a a a a |
Author keywords
Afatinib; Diarrhea; Hange shashin to
|
Indexed keywords
AFATINIB;
CISPLATIN;
HANGE SHASHIN TO;
PEMETREXED;
ANTINEOPLASTIC AGENT;
EGFR PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HANGE-SHASHINTO;
HERBACEOUS AGENT;
QUINAZOLINE DERIVATIVE;
ARTICLE;
CLINICAL ARTICLE;
COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
DIARRHEA;
HUMAN;
PHASE 3 CLINICAL TRIAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL;
AGED;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
GENETICS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DIARRHEA;
DRUGS, CHINESE HERBAL;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 84938808717
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (6)
|